FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This is the ...

William McCombe; Chief Financial Officer; Cytek Biosciences, Inc.

Cytek Biosciences, Inc. ( (CTKB) ) has released its Q3 earnings. Here is a breakdown of the information Cytek Biosciences, Inc. presented to ...

Operator: Thank you for standing by. At this time, I’d like to welcome everyone to the Cytek Biosciences’ Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to ...

Louisiana State Employees Retirement System lifted its position in Cytek Biosciences, Inc. (NASDAQ:CTKB – Free Report) by 6.8% in the 3rd quarter, according to its most recent Form 13F filing ...

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences in November. Guggenheim ...

Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com. Cytek’s products are for research use ...

Short interest in Cytek Biosciences Inc (NASDAQ:CTKB) increased during the last reporting period, rising from 4.30M to 4.47M. This put 4.36% of the company's publicly available shares short.

Cytek BioSciences Inc (NASDAQ: CTKB) has experienced a rise in its stock price by 29.04 compared to its previous closing price of 5.44. However, the company has seen a gain of 43.27% in its stock ...

On Wednesday, Cytek Biosciences Inc (CTKB) stock saw a modest uptick, ending the day at $7.4 which represents a slight increase of $1.96 or 36.03% from the prior close of $5.44. The stock opened at $5 ...